EGFR antibody (PE)
Quick Overview for EGFR antibody (PE) (ABIN2261117)
Target
See all EGFR AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Cross-Reactivity
- Human
-
Cross-Reactivity (Details)
- Calculated cross reactivity: Hu
-
Characteristics
- Epidermal Growth Factor Receptor (erbB, EGFR, EC 2.7.10.1, ERBB, ERBB1, HER1, MENA, PIG61) (PE)
-
Purification
- Purified by Protein G affinity chromatography.
-
Immunogen
- Extracellular domain of human EGF-receptor from head and neck carcinoma
-
Isotype
- IgG2a
-
-
-
-
Application Notes
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Reconstitute with 1 mL sterile 40-50 % glycerol, ddH2O.
-
Buffer
- Supplied as a lyophilized powder from PBS, pH 7.4, 1 % BSA, 0.09 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- -20°C
-
-
- EGFR (Epidermal Growth Factor Receptor (EGFR))
-
Alternative Name
- Epidermal Growth Factor Receptor
-
Pathways
- NF-kappaB Signaling, RTK Signaling, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Stem Cell Maintenance, Hepatitis C, Positive Regulation of Response to DNA Damage Stimulus, Interaction of EGFR with phospholipase C-gamma, Thromboxane A2 Receptor Signaling, EGFR Downregulation, S100 Proteins
Target
-